Research indicates wider benefit to AstraZeneca vaccine

A review of the COVID-19 vaccine trials indicate that adenovirus vectored vaccines may have non-specific protective effects resulting in significantly reduced all-cause mortality and non-COVID deaths, compared with mRNA based ...

Diseases, Conditions, Syndromes

Nasal COVID-19 vaccine approved for use as booster in India

A nasal COVID-19 vaccine based on technology licensed from Washington University in St. Louis has been approved for emergency use in India as a booster for people who have already received two doses of other COVID-19 vaccines. ...

Diseases, Conditions, Syndromes

Developing a vaccine against Chagas disease

Tulane University researchers are working on a new Chagas disease vaccine that prevents lasting heart damage, a long-term complication from the tropical disease.


Most common adverse events with JYNNEOS are nonserious

The JYNNEOS vaccine, which is recommended for persons exposed to or at high risk for exposure to mpox virus, seems safe, with the most common adverse health events reported as nonserious, according to research published ...

Diseases, Conditions, Syndromes

PRIORIX, M-M-R II vaccines interchangeable for MMR

The measles, mumps, and rubella (MMR) vaccines PRIORIX and M-M-R II are interchangeable, according to research published in the Nov. 18 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality ...

Diseases, Conditions, Syndromes

The tools Uganda is using to fight Ebola outbreak

New clinical trials of vaccines and drugs have helped bolster Uganda's arsenal of weapons to fight against an Ebola outbreak first detected two months ago.

page 1 from 40